Patrick J. Loll
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Patrick J. Loll has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Stephen D. Weeks
Laboratory for Biocrystallography, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
3 shared publications Kimberly C. Grasty
2 shared publicationsAnna Tretiakova
Department of Biochemistry, Drexel University College of Medicine, Philadelphia, PA 19102-1192, USA
1 shared publicationAriss Derhovanessian
Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA
1 shared publicationBarry S. Selinsky
Department of Chemistry, Villanova University, Villanova, PA 19085, USA
1 shared publicationErik Soderblom
Department of Biochemistry, Drexel University College of Medicine, Philadelphia, PA 19102-1192, USA
1 shared publication
Latest Publications
- Open Access
- 1 February 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (6) , 4555-4565
Crystal Structure of a Josephin-Ubiquitin Complex
- 1 February 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (6) , 4555-4565
Open AccessCrystal Structure of a Josephin-Ubiquitin Complex
- 12 August 2009
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 77 (4) , 753-759
Crystal structures of Lys‐63‐linked tri‐ and di‐ubiquitin reveal a highly extended chain architecture
The covalent attachment of different types of poly‐ubiquitin chains signal different outcomes for the proteins so targeted. For example, a protein modified with Lys‐48‐linked poly‐ubiquitin chains is targeted for proteasomal degradation, whereas Lys‐63‐linked chains encode nondegradative signals. The structural features that enable these different types of chains to encode different signals have not yet been fully elucidated. We report here the X‐ray crystal structures of Lys‐63‐linked tri‐ and di‐ubiquitin at resolutions of 2.3 and 1.9 Å, respectively. The tri‐ and di‐ubiquitin species adopt essentially identical structures. In both instances, the ubiquitin chain assumes a highly extended conformation with a left‐handed helical twist; the helical chain contains four ubiquitin monomers per turn and has a repeat length of ∼110 Å. Interestingly, Lys‐48 ubiquitin chains also adopt a left‐handed helical structure with a similar repeat length. However, the Lys‐63 architecture is much more open than that of Lys‐48 chains and exposes much more of the ubiquitin surface for potential recognition events. These new crystal structures are consistent with the results of solution studies of Lys‐63 chain conformation, and reveal the structural basis for differential recognition of Lys‐63 versus Lys‐48 chains. Proteins 2009.
- 12 August 2009
- Published by Wiley in Proteins: Structure, Function, and Bioinformatics
- Vol. 77 (4) , 753-759
Crystal structures of Lys‐63‐linked tri‐ and di‐ubiquitin reveal a highly extended chain architecture
The covalent attachment of different types of poly‐ubiquitin chains signal different outcomes for the proteins so targeted. For example, a protein modified with Lys‐48‐linked poly‐ubiquitin chains is targeted for proteasomal degradation, whereas Lys‐63‐linked chains encode nondegradative signals. The structural features that enable these different types of chains to encode different signals have not yet been fully elucidated. We report here the X‐ray crystal structures of Lys‐63‐linked tri‐ and di‐ubiquitin at resolutions of 2.3 and 1.9 Å, respectively. The tri‐ and di‐ubiquitin species adopt essentially identical structures. In both instances, the ubiquitin chain assumes a highly extended conformation with a left‐handed helical twist; the helical chain contains four ubiquitin monomers per turn and has a repeat length of ∼110 Å. Interestingly, Lys‐48 ubiquitin chains also adopt a left‐handed helical structure with a similar repeat length. However, the Lys‐63 architecture is much more open than that of Lys‐48 chains and exposes much more of the ubiquitin surface for potential recognition events. These new crystal structures are consistent with the results of solution studies of Lys‐63 chain conformation, and reveal the structural basis for differential recognition of Lys‐63 versus Lys‐48 chains. Proteins 2009.
- 1 January 2009
- Published by Elsevier in Journal of Molecular Biology
- Vol. 385 (1) , 200-211
Vancomycin Forms Ligand-Mediated Supramolecular Complexes
- 1 January 2009
- Published by Elsevier in Journal of Molecular Biology
- Vol. 385 (1) , 200-211
Vancomycin Forms Ligand-Mediated Supramolecular Complexes
- 1 May 2007
- Published by Elsevier in Protein Expression and Purification
- Vol. 53 (1) , 40-50
Ligation independent cloning vectors for expression of SUMO fusions
- 1 May 2007
- Published by Elsevier in Protein Expression and Purification
- Vol. 53 (1) , 40-50
Ligation independent cloning vectors for expression of SUMO fusions
- 18 January 2006
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 62 (2) , 151-156
2.0 Å structure of prostaglandin H2synthase-1 reconstituted with a manganese porphyrin cofactor
Prostaglandin H2 synthase (EC 1.14.99.1) is a clinically important drug target that catalyzes two key steps in the biosynthesis of the eicosanoid hormones. The enzyme contains spatially distinct cyclooxygenase and peroxidase active sites, both of which require a heme cofactor. Substitution of ferric heme by Mn(III) protoporphyrin IX greatly diminishes the peroxidase activity, but has little effect on the cyclooxygenase activity. Here, the 2.0 angstroms resolution crystal structure of the Mn(III) form of ovine prostaglandin H2 synthase-1 is described (R = 21.8%, R(free) = 23.7%). Substitution of Mn(III) for Fe(III) causes no structural perturbations in the protein. However, the out-of-plane displacement of the manganese ion with respect to the porphyrin is greater than that of the iron by approximately 0.2 angstroms. This perturbation may help to explain the altered catalytic properties of the manganese enzyme.
- 18 January 2006
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 62 (2) , 151-156
2.0 Å structure of prostaglandin H2synthase-1 reconstituted with a manganese porphyrin cofactor
Prostaglandin H2 synthase (EC 1.14.99.1) is a clinically important drug target that catalyzes two key steps in the biosynthesis of the eicosanoid hormones. The enzyme contains spatially distinct cyclooxygenase and peroxidase active sites, both of which require a heme cofactor. Substitution of ferric heme by Mn(III) protoporphyrin IX greatly diminishes the peroxidase activity, but has little effect on the cyclooxygenase activity. Here, the 2.0 angstroms resolution crystal structure of the Mn(III) form of ovine prostaglandin H2 synthase-1 is described (R = 21.8%, R(free) = 23.7%). Substitution of Mn(III) for Fe(III) causes no structural perturbations in the protein. However, the out-of-plane displacement of the manganese ion with respect to the porphyrin is greater than that of the iron by approximately 0.2 angstroms. This perturbation may help to explain the altered catalytic properties of the manganese enzyme.
- 23 May 2003
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 59 (6) , 1114-1116
Compatibility of detergents with the microbatch-under-oil crystallization method
Detergents are required to solubilize integral membrane proteins and are common components of the solutions used to crystallize these molecules. It has been unclear whether these detergents are completely compatible with the oils used in the microbatch-under-oil crystallization technique, because they might conceivably be lost from solution by partitioning into the oil phase. The partitioning of the detergents n-octyl-beta-d-glucopyranoside and Fos-Choline-12 into two different oils used for microbatch crystallization experiments has been examined. It was found that vigorous mixing and prolonged incubation of the aqueous detergent solutions with the oils leads to small losses of detergent (approximately 5% of the total detergent mass); however, gentle mixing that is more typical of the mixing encountered in a crystallization experiments leads to negligible loss of detergent.
- 23 May 2003
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 59 (6) , 1114-1116
Compatibility of detergents with the microbatch-under-oil crystallization method
Detergents are required to solubilize integral membrane proteins and are common components of the solutions used to crystallize these molecules. It has been unclear whether these detergents are completely compatible with the oils used in the microbatch-under-oil crystallization technique, because they might conceivably be lost from solution by partitioning into the oil phase. The partitioning of the detergents n-octyl-beta-d-glucopyranoside and Fos-Choline-12 into two different oils used for microbatch crystallization experiments has been examined. It was found that vigorous mixing and prolonged incubation of the aqueous detergent solutions with the oils leads to small losses of detergent (approximately 5% of the total detergent mass); however, gentle mixing that is more typical of the mixing encountered in a crystallization experiments leads to negligible loss of detergent.
- 1 April 2003
- Published by Elsevier in Journal of Structural Biology
- Vol. 142 (1) , 144-153
Membrane protein structural biology: the high throughput challenge
- 1 April 2003
- Published by Elsevier in Journal of Structural Biology
- Vol. 142 (1) , 144-153
Membrane protein structural biology: the high throughput challenge